Less Ads, More Data, More Tools Register for FREE

Edison

Edison's team of 50-plus analysts produces award-winning, tier one-standard equity research and investment analysis. In 2023, our international coverage includes daily in-depth scrutiny of over 225 stocks, connecting targeted investor groups across institutions, family offices, wealth managers and retail investors insight into our clients.

Edison specialises in expanding the global capital markets' understanding of our clients' investment cases. We do this through our unique combination of integrated services under the banner Complete IR which enhances our award-winning research with bespoke digital marketing services and investor relations engagement.
Date TIDM Title
09-Sep-24GRIDGresham House Energy Storage Fund - Revenue recovery to provide bas...
09-Sep-24AXS.AMAccsys Technologies - Second Accoya plant operational
09-Sep-24PEBBThe Pebble Group - Improved operational readiness
09-Sep-24MNPMartin Currie Global Portfolio Trust - Lower rates should be benefi...
09-Sep-24PCTNPicton Property Income - Office repurposing progress
09-Sep-24AAIFabrdn Asian Income Fund - Core Asian fund offering income and capit...
06-Sep-240FI1OPAP - Improved momentum in Q224
06-Sep-24EML Payments - Back to basics
05-Sep-24IRLAB Therapeutics - New mesdopetam patent strengthens IP portfolio
05-Sep-24RGTArgent Biopharma - An innovative approach to drug development
04-Sep-24Cereno Scientific - CS1 granted OMPD, complementing FDA ODD
03-Sep-24CGEOGeorgia Capital - Business as usual despite political turmoil
03-Sep-24FTCFiltronic - Upgrading on follow-on space order
03-Sep-24IHRImpact Healthcare REIT - Visible growth
02-Sep-24NANONanoco Group - European partnership not moving forward
02-Sep-24Nabaltec - Increasing profitability and margins
02-Sep-24Cereno Scientific - Pressing clinical assets forward to key inflection
30-Aug-24CoinShares International - Termination of coverage
29-Aug-24MYIMurray International Trust - Three become two – low-risk strategy m...
29-Aug-24CoinShares International - Resultatet från Q224formades av två engå...
28-Aug-24EPWNEpwin Group - Robust H1 performance in tough markets
28-Aug-240QNABasilea Pharmaceutica - EU paediatric approval triggers CHF10m mile...
27-Aug-24Actinogen Medical - Further positive XanaCIDD results on depression
27-Aug-24Mendus - Broad progress across the pipeline
27-Aug-24Argent Industrial - Argent expands internationally
23-Aug-24ZAL.OLZalaris - Tenth consecutive quarter of revenue growth
23-Aug-24CoinShares International - Q224 results shaped by two one-time events
23-Aug-24SIGA.USSIGA Technologies - TPOXX chalks up another DoD contract win
22-Aug-24TPTTopps Tiles - Acquisition of well-respected competitor
22-Aug-24Actinogen Medical - XanaCIDD data narrow the focus in depression